Interaction between Kynurenine and the AhR is an effector mechanism of tumor immunosuppression and represents a potential immunotherapy target

被引：0
|
作者：
Campesato, Luis Felipe [1 ]
Budhu, Sadna [1 ]
Tchaicha, Jeremy [2 ]
Pourpe, Stephane [1 ]
Liu, Cailian [1 ]
Manfredi, Mark G. [2 ]
McGovern, Karen [2 ]
Wolchok, Jedd D. [1 ]
Merghoub, Taha [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Kyn Therapeut, Austin, TX USA
来源：
JOURNAL OF IMMUNOLOGY | 2018年 / 200卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
177.5
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Investigating the kynurenine pathway as a central effector mechanism of tumor immune-suppression and its potential as therapeutic target
    Campesato, Luis Felipe
    Budhu, Sadna
    Zhang, X. Michelle
    Manfredi, Mark G.
    McGovern, Karen
    Wolchok, Jedd D.
    Merghoub, Taha
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [2] CD93 overexpresses in liver hepatocellular carcinoma and represents a potential immunotherapy target
    Jiang, Qianwei
    Kuai, Jing
    Jiang, Zhongyi
    Que, Weitao
    Wang, Pusen
    Huang, Wenxin
    Ding, Wei
    Zhong, Lin
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [3] Interplay between Estrogen, Kynurenine, and AHR Pathways: An immunosuppressive axis with therapeutic potential for breast cancer treatment
    Pacheco, Jorge Humberto Limon
    Elizondo, Guillermo
    BIOCHEMICAL PHARMACOLOGY, 2023, 217
  • [4] The Tumor Coagulome as a Transcriptional Target and a Potential Effector of Glucocorticoids in Human Cancers
    Racine, Floriane
    Louandre, Christophe
    Godin, Corinne
    Chatelain, Baptiste
    Prekovic, Stefan
    Zwart, Wilbert
    Galmiche, Antoine
    Saidak, Zuzana
    CANCERS, 2023, 15 (05)
  • [5] Icariside I - A novel inhibitor of the kynurenine-AhR pathway with potential for cancer therapy by blocking tumor immune escape
    Chen, Gui
    Huang, Jiajun
    Lei, Hehua
    Wu, Fang
    Chen, Chuan
    Song, Yuchen
    Cao, Zheng
    Zhang, Ce
    Zhang, Cui
    Ma, Yuxi
    Huang, Mingtao
    Zhou, Jinlin
    Lu, Yujing
    Zhao, Yanxia
    Zhang, Limin
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 153
  • [6] Overexpression of HER2 in head and neck cancer represents a potential target for T cell immunotherapy
    Warren, Emilie A.
    Liu, Hsuan-Chen
    Porter, Caroline E.
    Liao, Kershena S.
    Hegde, Meenakshi
    Yu, Wendong
    Castro, Patricia D.
    Sandulache, Vlad
    Ahmed, Nabil
    Suzuki, Masataka
    Sikora, Andrew
    CANCER RESEARCH, 2019, 79 (13)
  • [7] Tumor immunology - STAT3 - a potential target for tumour immunotherapy
    Buckland, J
    NATURE REVIEWS IMMUNOLOGY, 2004, 4 (02) : 82 - 83
  • [8] The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy
    Wenxiao Jia
    Qianqian Gao
    Anqin Han
    Hui Zhu
    Jinming Yu
    CancerBiology&Medicine, 2019, 16 (04) : 655 - 670
  • [9] The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy
    Jia, Wenxiao
    Gao, Qianqian
    Han, Anqin
    Zhu, Hui
    Yu, Jinming
    CANCER BIOLOGY & MEDICINE, 2019, 16 (04) : 655 - 670
  • [10] Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning
    Dirk Jäger
    Christian Taverna
    Alfred Zippelius
    Alexander Knuth
    Cancer Immunology, Immunotherapy, 2004, 53 : 144 - 147
12345